Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Influence of Human IgG Subclass and Allotype on Complement Activation.
Damelang T, de Taeye SW, Rentenaar R, Roya-Kouchaki K, de Boer E, Derksen NIL, van Kessel K, Lissenberg-Thunnissen S, Rooijakkers SHM, Jongerius I, Mebius MM, Schuurman J, Labrijn AF, Vidarsson G, Rispens T. Damelang T, et al. Among authors: schuurman j. J Immunol. 2023 Dec 1;211(11):1725-1735. doi: 10.4049/jimmunol.2300307. J Immunol. 2023. PMID: 37843500 Free PMC article.
Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
Larrick JW, Alfenito MR, Scott JK, Parren PW, Burton DR, Bradbury AR, Lemere CA, Messer A, Huston JS, Carter PJ, Veldman T, Chester KA, Schuurman J, Adams GP, Reichert JM. Larrick JW, et al. Among authors: schuurman j. MAbs. 2016 Nov/Dec;8(8):1425-1434. doi: 10.1080/19420862.2016.1227665. Epub 2016 Aug 24. MAbs. 2016. PMID: 27557809 Free PMC article.
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity.
Rider DA, Havenith CE, de Ridder R, Schuurman J, Favre C, Cooper JC, Walker S, Baadsgaard O, Marschner S, vandeWinkel JG, Cambier J, Parren PW, Alexander DR. Rider DA, et al. Among authors: schuurman j. Cancer Res. 2007 Oct 15;67(20):9945-53. doi: 10.1158/0008-5472.CAN-07-1148. Cancer Res. 2007. PMID: 17942927 Clinical Trial.
In situ depletion of CD4+ T cells in human skin by Zanolimumab.
Villadsen LS, Skov L, Dam TN, Dagnaes-Hansen F, Rygaard J, Schuurman J, Parren PW, van de Winkel JG, Baadsgaard O. Villadsen LS, et al. Among authors: schuurman j. Arch Dermatol Res. 2007 Feb;298(9):449-55. doi: 10.1007/s00403-006-0710-0. Epub 2006 Nov 8. Arch Dermatol Res. 2007. PMID: 17091277
Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study.
Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, Petersen LJ, Beurskens FJ, Schuurman J, van de Winkel JG, Parren PW, Gracie JA, Jongbloed S, Liew FY, McInnes IB. Baslund B, et al. Among authors: schuurman j. Arthritis Rheum. 2005 Sep;52(9):2686-92. doi: 10.1002/art.21249. Arthritis Rheum. 2005. PMID: 16142748 Free article. Clinical Trial.
Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.
Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, Rygaard J, Voorhorst-Ogink MM, Gerritsen AF, van Dijk MA, Parren PW, Baadsgaard O, van de Winkel JG. Villadsen LS, et al. Among authors: schuurman j. J Clin Invest. 2003 Nov;112(10):1571-80. doi: 10.1172/JCI18986. J Clin Invest. 2003. PMID: 14617758 Free PMC article.
112 results